SYK

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Gross Profit (TTM): 9158000000

Market Capitalization: 100881523000

Operating Margin (TTM): 0.22

PE Ratio: 53.83

PEG Ratio: 2.212

Profit Margin: 0.114

Revenue Per Share (TTM): 44.26

Revenue (TTM): 16669000000

Quarterly Earnings Growth YOY: -0.301

Quarterly Revenue Growth YOY: 0.113

Trailing PE: 53.83

Diluted EPS (TTM): 4.968

Dividend Date: 2022-01-31

Dividend Per Share: 2.52

Dividend Yield: 0.0103%

EBITDA: 4634000000

ExDividend Date: 2021-12-30

Forward Annual Dividend Rate:

Forward Annual Dividend Yield: